Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Li, Qin ^a   Yang, Zhen ^b   Lu, Bin ^a   Wen, Jie ^a   Ye, Zi ^a   Chen, Lili ^a   He, Min ^a   Tao, Xiaoming ^a   Zhang, Weiwei ^a   Huang, Ying ^a   Zhang, Zhaoyun ^a   Qu, Shen ^b   Hu, Renming ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atherosclerosis; Intima media thickness; Metabolic syndrome; Uric acid

Indexed keywords

C REACTIVE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; BODY MASS; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DRINKING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CHINA; ECHOGRAPHY; ETHNOLOGY; INCIDENCE; INTIMA; MIDDLE AGED; TUNICA MEDIA;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; URIC ACID;

EID: 79961112154     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-72     Document Type: Article

References (33)

1. Yamaoka-Tojo M, Tojo T, Takahira N, Matsunaga A, Aoyama N, Masuda T, Izumi T. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovascular Diabetology 2010, 9(17).
2. Gu DF, Reynolds K, Wu XG, Chen F, Duan XF, Reynolds RF, Whelton PK, He J, Inter ACG. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005, 365(9468):1398-1405. 10.1016/S0140-6736(05)66375-1, 15836888.
3. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum Uric Acid and Risk of Coronary Heart Disease: Atherosclerosis Risk in Communities (ARIC) Study. Annals of Epidemiology 2000, 10(3):136-143. 10.1016/S1047-2797(99)00037-X, 10813506.
4. So A, Thorens B. Uric acid transport and disease. Journal of Clinical Investigation 2010, 120(6):1791-1799. 10.1172/JCI42344, 2877959, 20516647.
5. Koenig W, Meisinger C. Uric acid, type 2 diabetes, and cardiovascular diseases: Fueling the common soil hypothesis?. Clinical Chemistry 2008, 54(2):231-233. 10.1373/clinchem.2007.099705, 18223129.
6. Meisinger C, Koenig W, Baumert J, Doring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population - The MONICA/KORA cohort study. Arteriosclerosis Thrombosis and Vascular Biology 2008, 28(6):1186-1192.
7. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension the PIUMA study. Hypertension 2000, 36(6):1072-1078.
8. Mankovsky B, Kurashvili R, Sadikot S. Is serum uric acid a risk factor for atherosclerotic cardiovascular disease?: A review of the clinical evidence. Part 1. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2010, 4(3):176-184.
9. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001, 38(5):1101-1106. 10.1161/hy1101.092839, 11711505.
10. Ishizaka N, Ishizaka Y, Toda E-I, Nagai R, Yamakado M. Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals. Arterioscler Thromb Vasc Biol 2005, 25(5):1038-1044. 10.1161/01.ATV.0000161274.87407.26, 15746438.
11. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. American Journal of Physiology - Renal Physiology 2006, 290(3):F625-F631.
12. Lu B, Wen J, Song XY, Dong XH, Yang YH, Zhang ZY, Zhao NQ, Ye HY, Mou B, Chen FL, Liu Y, Shen Y, Wang XC, Zhou LN, Li YM, Zhu XX, Hu RM. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Research and Clinical Practice 2007, 75(2):184-192. 10.1016/j.diabres.2006.06.024, 16893584.
13. Yang Z, Zhang ZY, Wen J, Wang XC, Lu B, Yang ZH, Zhang WW, Wang M, Feng XC, Ling C, Wu SH, Hu RM. Elevated Serum Chemokine CXC Ligand 5 Levels Are Associated with Hypercholesterolemia But Not a Worsening of Insulin Resistance in Chinese People. Journal of Clinical Endocrinology & Metabolism 2010, 95(8):3926-3932. 10.1210/jc.2009-2194, 21798986.
14. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419. 10.1007/BF00280883, 3899825.
15. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Diabetes 1999, 48(2):383-390. 2622732, 10334318, Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
16. Dagostino RB, Burke G, Oleary D, Rewers M, Selby J, Savage PJ, Saad MF, Bergman RN, Howard G, Wagenknecht L, Haffner SM. Ethnic differences in carotid wall thickness - The Insulin Resistance Atherosclerosis Study. Stroke 1996, 27(10):1744-1749. 10.1161/01.STR.27.10.1744, 8841322.
17. Wei M, Gonzalez C, Haffner SM, Oleary DH, Stern MP. Ultrasonographically assessed maximum carotid artery wall thickness in Mexico City residents and Mexican Americans living in San Antonio, Texas - Association with diabetes and cardiovascular risk factors. Arteriosclerosis Thrombosis and Vascular Biology 1996, 16(11):1388-1392.
18. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988, 70(3):253-261. 10.1016/0021-9150(88)90176-1, 3284536.
19. Lu B, Yang Y, Song X, Dong X, Zhang Z, Zhou L, Li Y, Zhao N, Zhu X, Hu R. An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism 2006, 55(8):1088-1096. 10.1016/j.metabol.2006.04.003, 16839846.
20. Liu J, Grundy SM, Wang W, Smith SC, Vega GL, Wu Z, Zeng Z, Wang W, Zhao D. Ethnic-Specific Criteria for the Metabolic Syndrome. Diabetes Care 2006, 29(6):1414-1416. 10.2337/dc06-0481, 16732037.
21. Kim ES, Kwon HS, Ahn CW, Lim DJ, Shin JA, Lee SH, Cho JH, Yoon KH, Kang MI, Cha BY, Son HY. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications 2010,
22. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2. Hypertension 2003, 41(6):1287-1293. 10.1161/01.HYP.0000072820.07472.3B, 12743010.
23. Baldwin W MS, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ, Sautin YY. Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome. Diabetes 2011, 60(4):1258-1269. 10.2337/db10-0916, 21346177.
24. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Seminars in Nephrology 2005, 25(1):39-42. 10.1016/j.semnephrol.2004.09.007, 15660333.
25. Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH. Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart and Vessels 2009, 24(5):371-375. 10.1007/s00380-008-1127-9, 19784821.
26. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M, Katoh T, Ohtsuka N. High-sensitivity c-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardiovascular Diabetology 2010, 9.
27. Pu LJ, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH, Shen WF. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovascular Diabetology 2006, 9.
28. Fukui M, Tanak M, Shiraishi E, Harusato I, Hosoda H, Asano M, Kadono M, Hasegawa G, Yoshikawa T, Nakamura N. Serum uric acid is associated with micro albuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism-Clinical and Experimental 2008, 57(5):625-629.
29. Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Internal Medicine 2006, 45(9):605-614. 10.2169/internalmedicine.45.1661, 16755091.
30. Butler R, Morris AD, Belch JJF, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000, 35(3):746-751.
31. Farquharson CA, Butler R, Hill A, Belch JJF, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002, 106(2):221-226. 10.1161/01.CIR.0000022140.61460.1D, 12105162.
32. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJS, Anker SD, Hambrecht R. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies. Circulation 2002, 105(22):2619-2624. 10.1161/01.CIR.0000017502.58595.ED, 12045167.
33. Facchini F, Chen Y-DI, Hollenbeck CB, Reaven GM. Relationship Between Resistance to Insulin-Mediated Glucose Uptake, Urinary Uric Acid Clearance, and Plasma Uric Acid Concentration. JAMA: The Journal of the American Medical Association 1991, 266(21):3008-3011.